Burns, Hypoglycemia
Conditions
Keywords
burns, hypoglycemia, hyperglycemia, glucose monitoring
Brief summary
This study is intended to fill the knowledge gap regarding the burn population with research that achieves scientific merit. we will determine the effectiveness of the computer decision support system (CDSS) to facilitate glucose management in the critically ill burn patient. The EndoTool™ computer decision support system will achieve glycemic control (defined as 80-110 mg/dL) in a shorter time, reduce glycemic excursion outside of target range, and reduce incidence of hypoglycemia (blood glucose less than 50 mg/dL) in the critically ill burn patient compared to the standard of care USAISR insulin titration protocol (Appendix A).
Detailed description
This is a prospective, paired, randomized, cross-over design, with two groups: current standard of care using the USAISR Burn Center insulin titration nomogram (Appendix A) and insulin management using EndoTool™ (MD Scientific, LLC) decision support software. Patients will thus serve as their own controls. Upon admission to the burn ICU, patients expected to require continuous insulin infusion for a minimum of 7 days will be placed on EndoTool™ CDSS for the first 24 hours of glycemic management. At the 24 hour mark the patients will be randomly assigned to either the CDSS or standard of care group in pairs. Thus, the first subject will be randomized to a group and the second subject will be placed in the alternate group. This method will ensure equal numbers of patients are enrolled in each group to eliminate bias of timing of intervention due to the effect of increasing insulin resistance over time demonstrated in the burn population (Pidcoke, unpublished, USAISR).
Interventions
Computer tool to help achieve glucose control
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 years or older * military or civilian burns on continuous insulin infusion for 7 days
Exclusion criteria
* not expected to receive insulin for 7 days * less than 18 years old * enrolled in the Continuous Glucose monitoring Study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time spent in target glucose range of 80-110 mg/dL. | 48 hours |
Secondary
| Measure | Time frame |
|---|---|
| Time to achieve target glucose of 80-110 mg/dL and number of hypoglycemic events less than 80 and 50 mg/dL. | 7 days |
Countries
United States